Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,700 | -1,200 | N/A | 102,000 | 67,500 |
| Depreciation Amortization | 22,100 | 9,200 | N/A | 20,000 | 13,500 |
| Income taxes - deferred | 2,900 | 3,200 | N/A | 31,500 | 29,800 |
| Accounts receivable | -24,400 | -5,900 | N/A | -28,700 | -11,100 |
| Accounts payable and accrued liabilities | -2,000 | -5,000 | N/A | -6,900 | -4,100 |
| Other Working Capital | -35,800 | -29,900 | N/A | -70,300 | -60,800 |
| Other Operating Activity | 61,000 | 26,700 | 0 | 80,200 | 47,100 |
| Operating Cash Flow | $28,500 | $-2,900 | $N/A | $127,800 | $81,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,900 | -1,500 | N/A | -2,800 | -2,100 |
| Net Acquisitions | -216,100 | -213,000 | N/A | N/A | N/A |
| Purchase Of Investment | -49,000 | -32,200 | N/A | -131,400 | -100,700 |
| Sale Of Investment | 108,900 | 88,700 | N/A | 86,600 | 71,300 |
| Investing Cash Flow | $-160,100 | $-158,000 | $N/A | $-47,600 | $-31,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 199,000 | 199,000 | N/A | 0 | N/A |
| Debt Issued | 204,000 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 1,000 | -1,900 | N/A | 85,900 | 84,900 |
| Common Stock Repurchased | -31,600 | -21,300 | N/A | -107,900 | -62,900 |
| Other Financing Activity | -200,600 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $171,800 | $175,800 | $N/A | $-22,000 | $22,000 |
| Exchange Rate Effect | -700 | 3,500 | N/A | -1,800 | -1,800 |
| Beginning Cash Position | 68,500 | 68,500 | N/A | 64,100 | 64,100 |
| End Cash Position | 108,000 | 86,900 | N/A | 120,500 | 134,700 |
| Net Cash Flow | $39,500 | $18,400 | $N/A | $56,400 | $70,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,500 | -2,900 | N/A | 127,800 | 81,900 |
| Capital Expenditure | -3,900 | -1,500 | N/A | -2,800 | -2,100 |
| Free Cash Flow | 24,600 | -4,400 | 0 | 125,000 | 79,800 |